WEKO3
-
RootNode
アイテム
Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen
https://repo.qst.go.jp/records/45634
https://repo.qst.go.jp/records/45634a7d3db55-4bb7-48e1-8e1d-a4dcef0e28a2
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2009-09-14 | |||||
| タイトル | ||||||
| タイトル | Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Miyamoto, Tadaaki
× Miyamoto, Tadaaki× Baba, Masayuki× Yamamoto, Naoyoshi× Koto, Masashi× Sugawara, Toshiyuki× Yashiro, Tomoyasu× Kadono, Kennosuke× Ezawa, Hidefumi× Tsujii, Hirohiko× Mizoe, Junetsu× Yoshikawa, Kyosan× Kandatsu, Susumu× Fujisawa, Takehiko× 宮本 忠昭× 馬場 雅行× 山本 直敬× 小藤 昌志× 菅原 俊幸× 矢代 智康× 上遠野 賢之助× 江澤 英史× 辻井 博彦× 溝江 純悦× 吉川 京燦× 神立 進× 藤澤 武彦 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Purpose: A phase I/II study on carbon ion radiotherapy for stage I non-small cell lung cancer (NSCLC) was first conducted from 1994 to 1999 and determined the optimal dose. Second, a phase II study using the optimal dose was performed. The purpose of the present study was to clarify the local control and 5-year survival rates. Methods and Materials: From April 1999 to December 2000, 50 patients with 51 primary lesions were treated. Using a fixed dose of 72GyE in 9 fractions over 3 weeks, the primary tumors were irradiated with carbon ion beams alone. The average age of the patients was 74.5 years. Thirty three (66%) of them were medically inoperable. Local control and survival were determined by using the Kaplan-Meier method and the data were statistically processed by using the long-rank test. Results: All patients were observed for a minimum of 5 years or until death with a median follow-up time of 59.2 months ranging from 6.0 months to 83.0 months. The local control rate for all patients was 94.7%. The patients five-year cause-specific survival rate was 75.7% (IA: 89.4 IB: 55.1), and overall survival 50.0% (IA: 55.2, IB: 42.9). No toxic reactions in the lung greater than grade 3 were detected. Conclusions: Carbon ion radiotherapy, a new treatment modality with superior benefits in terms of QOL and ADL, has been proven as a valid alternative to surgery for stage I NSCLC and to offer particular benefits especially for elderly and inoperable patients. |
|||||
| 書誌情報 |
International Journal of Radiation Oncology Biology Physics 巻 67, 号 3, p. 750-758, 発行日 2007-03 |
|||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 0360-3016 | |||||
| DOI | ||||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.1016/j.ijrobp.2006.10.006 | |||||
Share
Cite as
Miyamoto, Tadaaki, Baba, Masayuki, Yamamoto, Naoyoshi, Koto, Masashi, Sugawara, Toshiyuki, Yashiro, Tomoyasu, Kadono, Kennosuke, Ezawa, Hidefumi, Tsujii, Hirohiko, Mizoe, Junetsu, Yoshikawa, Kyosan, Kandatsu, Susumu, Fujisawa, Takehiko, 宮本 忠昭, 馬場 雅行, 山本 直敬, 小藤 昌志, 菅原 俊幸, 矢代 智康, 上遠野 賢之助, 江澤 英史, 辻井 博彦, 溝江 純悦, 吉川 京燦, 神立 進, 藤澤 武彦, n.d., Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen: 750–758 p.
Loading...
